| Expression System | HEK293 |
|---|
| Protein Tag | No tag |
|---|
| Purity | > 95% by SDS-PAGE under reducing conditions |
|---|
| Endotoxin | < 1 EU per ug by the LAL method |
|---|
| Activity | Positive |
|---|
| Conjugate | Unconjugated |
|---|
| Species | Human |
|---|
| Accession Number | P15692-4 |
|---|
| Protein Sequence | Ala27-Arg191 |
|---|
| Molecular Weight | The protein has a predicted molecular weight of 19kDa and migrates at approximately 20-30kDa on SDS-PAGE with DTT-reduced condition. |
|---|
| Formulation | Lyophilized powder from 0.22um filtered solution in PBS, pH 7.4, 8% trehalose |
|---|
| Purification | SEC |
|---|
| Applications | ELISA |
|---|
| Format | Lyophilized |
|---|
| Reconstitution | Centrifuge the tube before opening. Recommend reconstitute to a concentration > 100 ug/ml |
|---|
| Shipping Condition | Ambient |
|---|
| Storage/Shelf Life | <-20 °C for 12 months from the date of receipt; -80°C for 3 months after reconstitution. |
|---|
| Background Information | Human Vascular Endothelial Growth Factor (VEGF) is a protein that plays a crucial role in the development and maintenance of blood vessels. It is involved in both normal physiological processes like wound healing and pathological conditions like cancer. VEGF is a key regulator of angiogenesis, the formation of new blood vessels. |
|---|
